Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
Stock Information for Cidara Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.